The Cancer

Don't Miss

How Caregivers Can Assist Liked Ones With Lung Most cancers Really feel in Management

Chris Draft mentioned sufferers with lung most cancers and their caregivers can regain management after analysis by displaying up, staying knowledgeable and leaning into advocacy,...

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

Elaine Riozzi Bodine and her daughter Alayna turned a life-altering analysis right into a mission to help different adolescents and younger adults with most cancers....

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Vital Information

Facts

Latest Articles

Key Challenges and Therapy Insights

Dr. Breelyn Wilky, an affiliate professor of drugs within the Division of Medical Oncology on the College of Colorado, Anschutz Medical Campus, explains...

A Survivor and Affected person Advocate Displays on Beating Most cancers Twice

Daniel Jernazian, a two-time most cancers survivor, shares what formed his journey by means of sickness and restoration.After being recognized with Hodgkin lymphoma...

Celebrating Survival After Transplant: Appreciating My Donor

Mary Sansone is a two-time survivor of acute myeloid leukemia. Make amends for all of Mary's blogs right here!On June 5, 2025, I used...

Understanding Therapeutic Choices for ER+/HER2- Metastatic Breast Most cancers

Consultants talk about remedy choices for these with ER-positive, HER2-negative stage 4 breast most cancers: © inventory.adobe.com.For sufferers navigating a prognosis of estrogen...

FDA Approves Stoboclo and Osenvelt as Biosimilars Throughout Some Cancers

Stoboclo and Osenvelt, FDA-approved biosimilars of Prolia and Xgeva, are actually accessible: © inventory.adobe.com.Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo), biosimilars referencing Prolia (denosumab) and...

Hot Topics